Company intelligence / Profile preview

SIVA Health

Ownership: Private
Development stage: Commercial

Overview

SIVA Health has developed the first fully automated, CE-marked class IIa medical device system for continuous 24/7 cough detection. The system is clinically validated with proven performance in real-world studies. It is used by healthcare professionals, pharmaceutical companies, and researchers to monitor patients with respiratory conditions[1][2].

Therapeutic areas: Pulmonology
Modalities: DeviceDigital biomarker technology (sound-based)
Industry: Physiological Monitoring

Partnerships

Collaborations with global healthcare companies, researchers, clinics[1][2]

Beyond the preview

Go deeper on SIVA Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIVA Health.

Explore the full profile